Tofacitinib-13C, d3
Gecertificeerd

Tofacitinib-13C, d3

Catalog #: HY-40354S2
Maat: 1 Each

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

Description

Tofacitinib-13C, d3 (Tasocitinib-13C, d3) is 13C labeled Tofacitinib. Tofacitinib is an orally available JAK3/2/1 inhibitor with IC50s of 1, 20, and 112 nM, respectively.

Product Name Alternative

Tasocitinib-13C, d3; CP-690550-13C, d3

UNSPSC

12352005

Target

Isotope-Labeled Compounds

Related Pathways

Others

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology; Cancer

Smiles

C[C@H]1[C@H](CN(CC1)C(CC#N)=O)N(C2=C3C=CNC3=NC=N2)[13C]([2H])([2H])[2H]

Molecular Formula

C15 13CH17D3N6O

Molecular Weight

316.38

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.

Shipping Conditions

Room temperature

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-40354S2/

Scientific Category

Isotope-Labeled Compounds

Clinical Information

No Development Reported

Beschrijving

Tofacitinib-13C, d3 (Tasocitinib-13C, d3) is 13C labeled Tofacitinib. Tofacitinib is an orally available JAK3/2/1 inhibitor with IC50s of 1, 20, and 112 nM, res

Specificaties

ProductnaamTofacitinib-13C, d3
Categorie
Beschikbare grootte1 Each
CatalogusnummerHY-40354S2